Zhongzhi Pharmaceutical Holdings logo

3737 - Zhongzhi Pharmaceutical Holdings News Story

HK$1.4 0.0  0.0%

Last Trade - 7:01am

Sector
Consumer Defensives
Size
Small Cap
Market Cap £108.3m
Enterprise Value £96.8m
Revenue £176.2m
Position in Universe 3155th / 6091

BRIEF-Zhongzhi Pharmaceutical Holdings Says FY Profit Attributable RMB114.7 Mln

Wed 25th March, 2020 3:28pm
March 25 (Reuters) - Zhongzhi Pharmaceutical Holdings Ltd
 3737.HK :
    * RECOMMENDING A FINAL DIVIDEND OF HK2.9 CENTS PER SHARE AND
A
SPECIAL DIVIDEND OF HK1.45 CENTS PER SHARE
    * FY REVENUE RMB1.34 BILLION VERSUS RMB1.14 BILLION
    * FY PROFIT ATTRIBUTABLE RMB114.7 MILLION VERSUS RMB85.1
MILLION

Source text for Eikon:  ID:nHKS5rRL6W 
Further company coverage:  3737.HK 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.